Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mashima

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|April 26, 1995
Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cellsT Mashima, M Naito, S Kataoka, et al.
Cytotechnology|November 13, 2008
Apoptosis resistance in tumor cellsT Mashima, H Seimiya, Z Chen, et al.
Biomaterials|December 1, 1993
Bone-implant interface mechanics of in vivo bio-inert ceramicsK Hayashi, T Inadome, H Tsumura, et al.
Cell Death and Differentiation|October 14, 2003
Induction of in vitro nuclear apoptosis activity coincides with the production of 50 kDa cytosolic proteinM Naito, K Shiina, T Mashima, et al.
Oncogene|September 23, 2008
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditionsT Mashima, S Sato, Y Sugimoto, et al.
Journal of Cellular Physiology|January 15, 1998
Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-alpha-induced apoptosisJ Dong, M Naito, T Mashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cellsH Sakamoto, T Mashima, S Sato, et al.
Nihon Shishubyo Gakkai Kaishi|June 1, 1987
[Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]T Shimojima, T Mashima, K Hobo, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancerM Suenaga, T Mashima, N Kawata, et al.
Oncogene|February 18, 1999
Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cellsS Dan, M Naito, H Seimiya, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 26, 1995
Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cellsT Mashima, M Naito, S Kataoka, et al.
Cytotechnology|November 13, 2008
Apoptosis resistance in tumor cellsT Mashima, H Seimiya, Z Chen, et al.
Biomaterials|December 1, 1993
Bone-implant interface mechanics of in vivo bio-inert ceramicsK Hayashi, T Inadome, H Tsumura, et al.
Cell Death and Differentiation|October 14, 2003
Induction of in vitro nuclear apoptosis activity coincides with the production of 50 kDa cytosolic proteinM Naito, K Shiina, T Mashima, et al.
Oncogene|September 23, 2008
Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditionsT Mashima, S Sato, Y Sugimoto, et al.
Journal of Cellular Physiology|January 15, 1998
Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-alpha-induced apoptosisJ Dong, M Naito, T Mashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cellsH Sakamoto, T Mashima, S Sato, et al.
Nihon Shishubyo Gakkai Kaishi|June 1, 1987
[Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]T Shimojima, T Mashima, K Hobo, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancerM Suenaga, T Mashima, N Kawata, et al.
Oncogene|February 18, 1999
Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cellsS Dan, M Naito, H Seimiya, et al.
Pageof 5